In conclusion, mIF profiling of the immune landscape in pretreatment biopsy samples of esophageal cancer identified HLA-DR and CD8/CTLA-4 positivity to be significantly associated with TTP and DSS. The gene discussed is CTLA4; the disease is esophageal cancer.